These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15608674)

  • 1. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
    Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
    Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
    Shiota M; Tsunoda T; Song Y; Yokomizo A; Tada Y; Oda Y; Naito S
    BJU Int; 2011 Apr; 107(7):1148-53. PubMed ID: 20726978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
    Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
    Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
    Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure.
    Gutstein DE; Marks AR
    Heart Vessels; 1997; Suppl 12():53-7. PubMed ID: 9476544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
    Leong CT; Ong CK; Tay SK; Huynh H
    Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-dystrophin expression down-regulates IP3-mediated calcium release events in resting dystrophin-deficient muscle cells.
    Balghi H; Sebille S; Mondin L; Cantereau A; Constantin B; Raymond G; Cognard C
    J Gen Physiol; 2006 Aug; 128(2):219-30. PubMed ID: 16847098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
    Tada Y; Yokomizo A; Shiota M; Tsunoda T; Plass C; Naito S
    Int J Oncol; 2011 Sep; 39(3):727-33. PubMed ID: 21617853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity.
    Seres M; Poláková E; Krizanová O; Hudecová S; Klymenko SV; Breier A; Sulová Z
    Gen Physiol Biophys; 2008 Sep; 27(3):211-21. PubMed ID: 18981537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.
    Tanabe M; Izumi H; Ise T; Higuchi S; Yamori T; Yasumoto K; Kohno K
    Cancer Res; 2003 Dec; 63(24):8592-5. PubMed ID: 14695168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressor domain of inositol 1,4,5-trisphosphate receptor plays an essential role in the protection against apoptosis.
    Szlufcik K; Bultynck G; Callewaert G; Missiaen L; Parys JB; De Smedt H
    Cell Calcium; 2006 Apr; 39(4):325-36. PubMed ID: 16458354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
    Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
    Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
    Wu ZZ; Lu HP; Chao CC
    Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.